IOVA vs SBAC · rev $170.7M vs P/E 30, rev $1.42B
Iovance Biotherapeutics Inc (IOVA) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
IOVA currently screens at market cap $1.89B. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the IOVA and SBAC stock pages for the full models.
Not investment advice.